七月 2026
- Home
- Cognate BioServices
七月 2026的Cognate BioServices市场份额分析
cognate is the premier biologics cdmo. we provide the broadest range of services for regenerative medicine, cellular immunotherapy, and cell therapy.
Cognate BioServices(包含公司地区分支机构)
查看更多网站流量和参与度信息- cognatebioservices.com
Cognate BioServices收入截至 七月 2026为 100M - 200M
Cognate BioServices主要域名产生的收入
3 年中Cognate BioServices主要域名的收入
Cognate BioServices主要域名的收入
Cognate BioServices热门域名的总访问量
了解Cognate BioServices市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Cognate BioServices热门域名的平均访问时长
分析Cognate BioServices参与度指标。
过去 3 个月的平均访问时长
子公司明细
Cognate BioServices热门域名的平均页面浏览量
了解Cognate BioServices如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Cognate BioServices 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Piré leaves Cognatebioservices as chief legal officer and global head of sustainability.Abbasi joins from Symbotic where she served as chief human resources officer, while Piré joins from Cognate BioServices where she was chief legal officer and global head of sustainability.
七月 13, 2022阅读更多
新闻Cognatebioservices expands facilities to United States, Northern America, Americas.Under his leadership, Cognate grew from relative obscurity to the leading international CDMO for cell and gene therapy with revenue in excess of $120 million, and manufacturing facilities in the US, the UK and Sweden.
七月 12, 2022阅读更多
新闻Charles River Laboratories International, Inc. acquired Cognatebioservices for $875M on Jan 1st '21.For instance, in February 2021, Charles River Laboratories, Inc. has announced the acquisition of Cognate BioServices, Inc., a leading cell and gene therapy contract development and manufacturing organization (CDMO), which has $875 million in cash, subject to customary closing adjustments.
一月 31, 2022阅读更多
查看 Cognate BioServices 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
